Tag Archives: SCHW

Top 5 Safest Stocks To Buy For 2019

In a junior sector that has become quite a stock-picker’s market over the past nine months, I find some of the safest and lowest risk opportunities come when a company is undergoing a major change. Atlantic Gold (OTCPK:SPVEF) was one such idea I highlighted last year, as the company was set to transform itself into Canada’s newest junior gold producer. The stock has since moved from US$0.60 to US$1.40 and the re-rating I expect has nearly come to fruition. A company with a similar profile that I’ve had my eye on was Harte Gold (OTCPK:HRTFF), but the stock got well ahead of itself earlier this year and I exited my position. Since that time the stock has spent the last six months consolidating and finally looks it may be ready to resume the new uptrend it began earlier this year.

Top 5 Safest Stocks To Buy For 2019: RetailMeNot, Inc.(SALE)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Headlines about RetailMeNot (NASDAQ:SALE) have been trending somewhat positive this week, according to Accern Sentiment. The research group rates the sentiment of press coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. RetailMeNot earned a news sentiment score of 0.18 on Accern’s scale. Accern also gave news headlines about the technology company an impact score of 45.6302865418039 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

Top 5 Safest Stocks To Buy For 2019: The Charles Schwab Corporation(SCHW)

Advisors’ Opinion:

  • [By ]

    TheStreet’s Scott Gamm recently spokes with Jake Gilliam, senior multiasset-class portfolio strategist at Charles Schwab (SCHW) about who uses target-date funds and why.

  • [By Shane Hupp]

    Envestnet Asset Management Inc. raised its stake in Charles Schwab Co. Common Stock (NYSE:SCHW) by 34.9% during the second quarter, Holdings Channel reports. The firm owned 227,086 shares of the financial services provider’s stock after purchasing an additional 58,715 shares during the period. Envestnet Asset Management Inc.’s holdings in Charles Schwab Co. Common Stock were worth $11,604,000 at the end of the most recent quarter.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Charles Schwab Co. Common Stock (SCHW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By ]

    Darn hard to not like the numbers out of Action Alerts PLUS holding JPMorgan & Chase (JPM) . Profits up nicely in all segments vs. the fourth quarter. Big year-over-year spikes in return on assets and equity from a year ago. Trading revenue up thanks to the return of volatility in the first quarter (can’t wait to see the blowout quarters from TD Ameritrade (AMTD) and Schwab (SCHW) ). Good card revenue growth from the fourth-quarter bodes well for retailer’s first-quarter results.

  • [By Joseph Griffin]

    Charles Schwab Co. Common Stock (NYSE:SCHW) was downgraded by analysts at ValuEngine from a buy rating to a hold rating.

    SemGroup (NYSE:SEMG) was downgraded by analysts at ValuEngine from a hold rating to a sell rating.

  • [By Logan Wallace]

    Charles Schwab Co. (NYSE:SCHW) – Equities researchers at Jefferies Financial Group upped their Q3 2018 earnings estimates for shares of Charles Schwab in a research note issued on Wednesday, September 19th. Jefferies Financial Group analyst D. Fannon now expects that the financial services provider will post earnings of $0.64 per share for the quarter, up from their previous estimate of $0.63. Jefferies Financial Group has a “Buy” rating and a $66.00 price objective on the stock. Jefferies Financial Group also issued estimates for Charles Schwab’s Q4 2018 earnings at $0.66 EPS and Q1 2019 earnings at $0.64 EPS.

Top 5 Safest Stocks To Buy For 2019: Reliv’ International Inc.(RELV)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Headlines about Reliv International (NASDAQ:RELV) have trended somewhat positive recently, according to Accern. The research group ranks the sentiment of news coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Reliv International earned a news sentiment score of 0.06 on Accern’s scale. Accern also assigned news articles about the company an impact score of 46.5816094320485 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Top 5 Safest Stocks To Buy For 2019: Callaway Golf Company(ELY)

Advisors’ Opinion:

  • [By Chris Hill]

    Moser: In the spirit of the Ryder Cup, which starts next Friday, looking a little bit more closely at Callaway Golf (NYSE:ELY), ticker ELY. For the most part, I’ve eschewed investing in golf altogether, with my experience in the business. It’s just not the highest margin game. I’m actually more interested in Callaway’s minority stake in Top Golf, which is the driving range concept that marries hitting golf balls with the social dynamic, as well. You meet your friends there for food, drinks, they have sports on TV and whatnot. There are around 41 Top Golfs today. The goal is to open another 100 here domestically, as well as 100 internationally. Already very profitable, and Callaway has about a 14% minority stake in it. They intend to continue investing in it. It’s got my attention.

  • [By Max Byerly]

    Shares of Ely Gold Royalties Inc (CVE:ELY) hit a new 52-week high on Thursday . The stock traded as high as C$0.18 and last traded at C$0.18, with a volume of 45000 shares changing hands. The stock had previously closed at C$0.17.

  • [By Evan Niu, CFA]

    Shares of Callaway Golf (NYSE:ELY) have jumped today, up by 12% as of 11:30 a.m. EDT, after the company reported second-quarter earnings results. The maker of golf products exceeded analysts’ expectations and boosted its full-year guidance for 2018.

  • [By Stephan Byrd]

    Elysian (CURRENCY:ELY) traded down 2.1% against the dollar during the one day period ending at 17:00 PM E.T. on September 24th. Over the last seven days, Elysian has traded up 35.1% against the dollar. One Elysian token can currently be purchased for about $0.0046 or 0.00000069 BTC on cryptocurrency exchanges including Hotbit, Stocks.Exchange, YoBit and Mercatox. Elysian has a market capitalization of $368,237.00 and approximately $225,690.00 worth of Elysian was traded on exchanges in the last day.

  • [By Shane Hupp]

    Elysian (CURRENCY:ELY) traded 2.8% higher against the dollar during the 1-day period ending at 23:00 PM Eastern on July 20th. In the last seven days, Elysian has traded flat against the dollar. One Elysian token can now be bought for about $0.0206 or 0.00000282 BTC on cryptocurrency exchanges including Hotbit, Qryptos, BitForex and IDEX. Elysian has a total market capitalization of $0.00 and $6.33 million worth of Elysian was traded on exchanges in the last 24 hours.

Top 5 Safest Stocks To Buy For 2019: Westinghouse Air Brake Technologies Corporation(WAB)

Advisors’ Opinion:

  • [By Lee Samaha]

    Just as promised on its first-quarter earnings call, General Electric Company (NYSE:GE) has announced a deal to exit its transportation business as part of a wider plan to unload $20 billion worth of assets. The deal to merge GE transportation with Westinghouse Air Brake Technologies (NYSE:WAB), or Wabtec, is somewhat complicated, but in general can be seen as a near-term positive for shareholders. However, it will do little to appease dyed-in-the-wool bears worried about the sustainability of the company’s dividend and restructuring prospects. Let’s take a look at both sides of the story.

  • [By Adam Levine-Weinberg]

    On Monday, General Electric announced its biggest divestiture yet. The company is set to merge its transportation business, which primarily builds railroad locomotives, with Westinghouse Air Brake Technologies (NYSE:WAB) — better known as Wabtec. This deal will generate a sizable cash windfall, and GE shareholders will also receive a substantial stake in Wabtec.

  • [By Lisa Levin] Gainers
    SenesTech, Inc. (NASDAQ: SNES) shares jumped 113.5 percent to $0.6737 after the California Department of Pesticide Regulation proposed to register the company's ContraPest for sale and use in California.
    AgEagle Aerial Systems, Inc. (NASDAQ: UAVS) shares rose 35.34 percent to close at $3.32.
    Art's-Way Manufacturing Co., Inc. (NASDAQ: ARTW) shares gained 30.36 percent to $3.65.
    Xtant Medical Holdings, Inc. (NYSE: XTNT) shares jumped 25.6 percent to $7.4701 after the company disclosed that it has received the FDA clearance for InTice™-C Porous Titanium Cervical Interbody System.
    VAALCO Energy, Inc. (NYSE: EGY) shares surged 20 percent to $2.495.
    TransGlobe Energy Corporation (NASDAQ: TGA) surged 17.04 percent to $2.61.
    Boxlight Corporation (NASDAQ: BOXL) gained 15 percent to $8.32 after the company announced an exclusive partnership with Multi Touch Interactives to strengthen the development of next generation interactive educational activities.
    Arcimoto, Inc. (NASDAQ: FUV) gained 15 percent to $3.39.
    MB Financial, Inc. (NASDAQ: MBFI) rose 13.7 percent to $49.64. Fifth Third Bancorp (NASDAQ: FITB) agreed to acquire MB Financial for $54.70 per share in cash and stock.
    FRONTEO, Inc. (NASDAQ: FTEO) shares rose 11.8 percent to $20.956.
    TransEnterix, Inc. (NYSE: TRXC) shares jumped 11.1 percent to $3.38.
    21Vianet Group, Inc. (NASDAQ: VNET) rose 10.6 percent to $7.41.
    NII Holdings, Inc. (NASDAQ: NIHD) shares gained 9 percent to $2.32.
    Kelly Services, Inc. (NASDAQ: KELYA) rose 7.6 percent to $24.19. Northcoast Research upgraded Kelly Services from Neutral to Buy.
    LaSalle Hotel Properties (NYSE: LHO) shares climbed 5.6 percent to $33.70. Blackstone Group LP (NYSE: BX) will buy LaSalle Hotel Properties in a $4.8 billion deal, Bloomberg reported.
    Alteryx, Inc. (NYSE: AYX) gained 5.5 percent to $32.56. KeyBanc upgraded Alteryx from Sector Weight to Overweight.
    Energizer Holdings, Inc. (NYSE:
  • [By Adam Levine-Weinberg]

    And last month, GE signed a complex deal to sell its transportation business — which specializes in building freight locomotives — to Westinghouse Air Brake Technologies (NYSE:WAB), better known as Wabtec.

  • [By Logan Wallace]

    California Public Employees Retirement System raised its stake in Westinghouse Air Brake Technologies Corp (NYSE:WAB) by 2.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 212,509 shares of the transportation company’s stock after purchasing an additional 5,052 shares during the period. California Public Employees Retirement System owned 0.22% of Westinghouse Air Brake Technologies worth $17,298,000 as of its most recent SEC filing.

  • [By Ethan Ryder]

    Shares of Westinghouse Air Brake Technologies Corp (NYSE:WAB) were down 12.4% on Friday . The company traded as low as $96.56 and last traded at $98.21. Approximately 6,582,509 shares traded hands during mid-day trading, an increase of 707% from the average daily volume of 815,360 shares. The stock had previously closed at $112.12.

Best Blue Chip Stocks To Buy For 2019

The Dow Jones was up nearly 400 points today, led by blue chips Walmart and Boeing.

Walmart soared after posting its best sales in over a decade.

Boeing jumped on hopeful reports that U.S.-Chinese trade talks will soon resume.

And so the daily soap opera continues, with its twisting plots, rotating characters… and fleeting love affairs.

Turkey, the past week’s main antagonist, has gone offstage — at least for now.

But for how long?

Let us briefly revisit the last emerging-markets crisis in search of light…

The crisis was in swing by early July 1997, when Thailand suddenly devalued its currency.

Panic spread throughout emerging markets as Indonesia and others followed in train.

Anxious credit fled emerging markets as fast as legs could take it.

But the drama did not impact U.S. stock markets for months.

It was not until late October that the blade swung this way… nearly four months later.

As Nicholas Colas, co-founder of DataTrek Research, notes:

Best Blue Chip Stocks To Buy For 2019: John Hancock Financial Opportunities Fund(BTO)

Advisors’ Opinion:

  • [By Stephan Byrd]

    B2Gold Corp. (TSE:BTO) (NYSE:BTG) – Research analysts at National Bank Financial issued their Q3 2018 earnings per share estimates for shares of B2Gold in a report released on Wednesday, August 15th. National Bank Financial analyst D. Demarco anticipates that the company will post earnings per share of $0.05 for the quarter. National Bank Financial currently has a “Outperform” rating and a $6.50 target price on the stock. National Bank Financial also issued estimates for B2Gold’s FY2020 earnings at $0.30 EPS.

  • [By ]

    One of my favorites is the JH Financial Opportunities Fund (NYSE: BTO), which targets banks and brokerage firms. The fund offers a dividend yield of about 4% and has generated returns in the top 1% of its category over the past 1-,3-,5-,10- and 15-year periods. At last count, my High-Yield Investing subscribers and I were up 23% on the fund in a little over a year and a half.

  • [By Stephan Byrd]

    B2Gold (TSE:BTO) (NYSE:BTG) had its price objective trimmed by Pi Financial from C$5.25 to C$5.10 in a research report released on Friday.

    A number of other research firms have also recently weighed in on BTO. Canaccord Genuity lowered their target price on shares of B2Gold from C$7.00 to C$6.50 in a research note on Tuesday, July 24th. National Bank Financial lowered their target price on shares of B2Gold from C$7.00 to C$6.50 and set an outperform rating on the stock in a research note on Saturday, July 14th. Scotiabank reissued an outperform rating and issued a C$5.00 target price on shares of B2Gold in a research note on Monday, May 28th. Finally, Royal Bank of Canada lowered their target price on shares of B2Gold from C$5.00 to C$4.50 and set an outperform rating on the stock in a research note on Tuesday, May 22nd. Six investment analysts have rated the stock with a buy rating, B2Gold presently has a consensus rating of Buy and an average target price of C$5.38.

Best Blue Chip Stocks To Buy For 2019: The Charles Schwab Corporation(SCHW)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    And with just a few smart plays in today’s classic stock picker’s market, you can pull in triple-digit gains with just a small investment.

    The Top Stock Market Stories for Tuesday
    The markets are upbeat about the latest reports surrounding trade between the United States and China. Despite news that roughly $16 billion in fresh tariffs are going into effect this week on Chinese goods, markets are hoping that momentum begins to build ahead of discussions between leaders of world’s two largest economies. With that said, President Trump downplayed upcoming discussions in an interview with Reuters on Monday. Back on June 21, I wrote about a fast-moving, high-profit stock – Dover Downs Gaming & Entertainment Inc. (NYSE: DDE). And that recommendation has brought in gains of roughly 103% since then. But we’re not done with the top gambling stocks. Today, I’m back with an entirely different way to make fast gains in this space. To see the latest bargain play, read up on this fund that no one is talking about. We’re talking a quick double-digit gain, no questions asked
    Three Stocks to Watch Today: KSS, JPM, TSLA
    Kohl’s Corp. (NYSE: KSS) leads a busy day of earnings reports on Tuesday. This morning, the retailer reported earnings of share of $1.76. That figure topped Wall Street estimates by $0.12. Shares pressed higher thanks to news of a 3.1% jump in same-store sales and a hike to the retailer’s full-year outlook. JPMorgan Chase & Co. (NYSE: JPM) is on the verge of blowing up the retail stock trading business. The global investment bank is set to release a free digital application that allows investors to trade stocks for free or at a discounted price. Users will be able to obtain up to 100 free trades in their first year after downloading the app. The news hammered brokerage stocks like Charles Schwab Corp. (NYSE: SCHW), E*Trade Financial Corp. (Nasdaq: ETFC), and TD Ameritrade Holding Corp. (Nasdaq: AMTD). Things are looking ugly for automa

  • [By Ethan Ryder]

    Rockefeller Capital Management L.P. purchased a new stake in shares of Charles Schwab Co. (NYSE:SCHW) in the first quarter, HoldingsChannel.com reports. The institutional investor purchased 11,591 shares of the financial services provider’s stock, valued at approximately $605,000.

  • [By Stephan Byrd]

    Zurcher Kantonalbank Zurich Cantonalbank grew its position in Charles Schwab Co. (NYSE:SCHW) by 1.1% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 253,187 shares of the financial services provider’s stock after acquiring an additional 2,700 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Charles Schwab were worth $13,221,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Jon C. Ogg]

    Charles Schwab Corp. (NYSE: SCHW) is the largest of the online and discount brokerages, with a $67 billion market value, and it also has gone into very low-fee funds of its own. Still, its shares were down 3.3% at $49.71 on the news that JPMorgan was getting into the game of no-fee investing. Schwab has a consensus analyst price target of $60.00 and a 52-week range of $38.06 to $60.22.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Charles Schwab (SCHW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Blue Chip Stocks To Buy For 2019: Vanguard FTSE Europe ETF (VGK)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Round Table Services LLC acquired a new position in Vanguard FTSE Europe ETF (NYSEARCA:VGK) in the second quarter, Holdings Channel reports. The firm acquired 5,122 shares of the exchange traded fund’s stock, valued at approximately $287,000.

  • [By Max Byerly]

    Tocqueville Asset Management L.P. raised its stake in Vanguard FTSE Europe ETF (NYSEARCA:VGK) by 8.0% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 166,329 shares of the exchange traded fund’s stock after buying an additional 12,335 shares during the quarter. Tocqueville Asset Management L.P.’s holdings in Vanguard FTSE Europe ETF were worth $9,336,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Shane Hupp]

    Investors purchased shares of Vanguard FTSE Europe ETF (NYSEARCA:VGK) on weakness during trading on Wednesday. $88.65 million flowed into the stock on the tick-up and $33.76 million flowed out of the stock on the tick-down, for a money net flow of $54.89 million into the stock. Of all stocks tracked, Vanguard FTSE Europe ETF had the 15th highest net in-flow for the day. Vanguard FTSE Europe ETF traded down ($0.94) for the day and closed at $54.60

Best Blue Chip Stocks To Buy For 2019: China Advanced Construction Materials Group, Inc.(CADC)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 155.56 percent to close at $5.75 on Thursday.
    Inspire Medical Systems, Inc. (NYSE: INSP) shares gained 56.12 percent to close at $24.98. Inspire Medical went public Thursday on the New York Stock Exchange. The company issued 6.75 million shares priced at $16 each.
    Presbia PLC (NASDAQ: LENS) shares rose 53.02 percent to close at $3.55.
    Integrated Media Technology Limited (NASDAQ: IMTE) shares rose 46.29 percent to close at $32.11. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.
    Technical Communications Corporation (NASDAQ: TCCO) climbed 27.78 percent to close at $5.75.
    STAAR Surgical Company (NASDAQ: STAA) shares gained 26.27 percent to close at $21.15 after reporting upbeat Q1 results.
    Sharing Economy International Inc. (NASDAQ: SEII) shares jumped 22.16 percent to close at $4.30 on Thursday after gaining 9.32 percent on Wednesday.
    China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) rose 20.45 percent to close at $2.65 on Thursday.
    YRC Worldwide Inc. (NASDAQ: YRCW) surged 18.36 percent to close at $9.99 following upbeat quarterly earnings.
    MYR Group Inc. (NASDAQ: MYRG) jumped 17.68 percent to close at $35.74 after the company posted strong Q1 earnings.
    Xspand Products Lab Inc (NASDAQ: XSPL) jumped 17.4 percent to close at $5.87. Xspand Products priced its IPO at $5 per share.
    Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose 17.32 percent to close at $14.90. Coherus BioSciences reported resubmission of BLA for CHS-1701.
    Rudolph Technologies, Inc. (NASDAQ: RTEC) shares gained 17.17 percent to close at $31.05 following upbeat quarterly earnings.
    The Meet Group, Inc. (NASDAQ: MEET) gained 16.02 percent to close at $2.68 following Q1 earnings.
    Ca
  • [By Lisa Levin] Gainers
    Axovant Sciences Ltd. (NASDAQ: AXON) shares rose 23.7 percent to $1.49. Axovant announced strengthening of management team and completion of organization restructuring which "enhanced capabilities in research and business development" and reduced internal headcount by 43 percent.
    Mammoth Energy Services, Inc. (NASDAQ: TUSK) shares jumped 19.8 percent to $37.3148. Mammoth Energy’s subsidiary Cobra signed a new $900 million contract to finish the restoration of critical electrical services and support the initial phase of reconstruction of the electrical utility system in Puerto Rico.
    Acorn International, Inc. (NYSE: ATV) shares gained 19 percent to $34.0201. Acorn shares rose Friday after the company declared a special one-time cash dividend of $14.97 per ADS.
    DHI Group, Inc. (NYSE: DHX) shares surged 19 percent to $2.20.
    My Size, Inc. (NASDAQ: MYSZ) climbed 16.8 percent to $1.18 after the company received a Notice of Allowance from the USPTO for measurement technology patent.
    Global Eagle Entertainment Inc. (NASDAQ: ENT) gained 16.6 percent to $2.32.
    Leju Holdings Limited (NYSE: LEJU) gained 16.5 percent to $1.34 following Q1 beat.
    Evolus, Inc. (NASDAQ: EOLS) shares surged 16.5 percent to $26.1499. Evolus named Lauren Silvernail as Chief Financial Officer and Executive Vice President, Corporate Development.
    Jupai Holdings Limited (NYSE: JP) shares gained 15 percent to $26.29 after reporting Q1 results.
    Momo Inc. (NASDAQ: MOMO) shares gained 15 percent to $44.7702 after the company reported better-than-expected results for its first quarter and issued strong sales forecast for the second quarter.
    Windstream Holdings, Inc. (NASDAQ: WIN) rose 15 percent to $7.075.
    China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) gained 14.4 percent to $2.746.
    American Woodmark Corporation (NASDAQ: AMWD) climbed 14.2 percent to $101.10 after the company reported upbeat Q4 results.
    Savara Inc. (NAS

Best Blue Chip Stocks To Buy For 2019: Bluerock Residential Growth REIT, Inc.(BRG)

Advisors’ Opinion:

  • [By Shane Hupp]

    A number of research analysts have commented on BRG shares. Zacks Investment Research raised shares of Bluerock Residential Growth REIT from a “hold” rating to a “buy” rating and set a $12.00 target price on the stock in a research report on Friday, February 15th. Boenning Scattergood reissued a “buy” rating and set a $11.00 target price on shares of Bluerock Residential Growth REIT in a research report on Tuesday, November 6th. B. Riley reissued a “buy” rating on shares of Bluerock Residential Growth REIT in a research report on Tuesday, November 6th. Finally, TheStreet raised shares of Bluerock Residential Growth REIT from a “d+” rating to a “c-” rating in a research report on Thursday, January 24th. One research analyst has rated the stock with a hold rating and three have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $11.17.

    COPYRIGHT VIOLATION NOTICE: “Bluerock Residential Growth REIT Inc (BRG) Shares Sold by National Asset Management Inc.” was originally posted by Ticker Report and is the property of of Ticker Report. If you are viewing this piece of content on another site, it was illegally copied and republished in violation of US and international trademark and copyright laws. The original version of this piece of content can be viewed at https://www.tickerreport.com/banking-finance/4188619/bluerock-residential-growth-reit-inc-brg-shares-sold-by-national-asset-management-inc.html.

    About Bluerock Residential Growth REIT

  • [By Shane Hupp]

    Bluerock Residential Growth REIT Inc Class A (NYSEAMERICAN:BRG) was the target of a large decrease in short interest in August. As of August 31st, there was short interest totalling 1,697,945 shares, a decrease of 7.7% from the August 15th total of 1,840,022 shares. Approximately 7.2% of the shares of the company are short sold. Based on an average daily trading volume, of 110,334 shares, the days-to-cover ratio is presently 15.4 days.

  • [By Ethan Ryder]

    Press coverage about Bluerock Residential Growth REIT (NASDAQ:BRG) has trended somewhat positive on Sunday, according to Accern. Accern rates the sentiment of press coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Bluerock Residential Growth REIT earned a media sentiment score of 0.02 on Accern’s scale. Accern also gave news stories about the company an impact score of 47.1792961215955 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Online Trading In 2018: Brokerage Execs Talk Mobile Apps, Cryptocurrency And Regulation

Brokerage expert Theresa Carey took the temperature of top executives from the sector at the 2018 Benzinga Global Fintech Awards on emerging trends in a sector that’s rapidly shifting to mobile platforms and intersecting with new instruments such as cryptocurrencies.

European Data Rules Kick In 

The European Union’s General Data Protection Regulation takes effect May 25, and Steve Sanders, the executive vice president of marketing and product development at Interactive Brokers (NASDAQ: IBKR), described it as the “bane of my existence.” Compliance with the regulations is taking resources from other products at the online brokerage, he said.

A similar legislation of data privacy is likely in the U.S., but might be “not as harsh,” Sanders told Carey during the panel discussion.

“Personally, I think everyone should just have an opt-out [or] unsubscribe at the end of the email.”

Differing Cryptocurrency Approaches

After CBOE Global Markets Inc (NASDAQ: CBOE) launched bitcoin futures in December, Charles Schwab Corporation (NYSE: SCHW) didn't immediately make the product available to clients, said Barry Metzger, the brokerage’s senior vice president of global, trading and advice.

That's in contrast to fellow panelists TD Ameritrade (NASDAQ: AMTD) and Interactive Brokers, both of which made bitcoin futures available as soon as they went live.

Schwab tests the liquidity and volatility of new issues before releasing them to clients, Metzger said.

“We want to make sure clients aren’t going to blow themselves up.”

Some of the “sizzle” of cryptocurrencies has come and gone, Metzger said, noting that Schwab will take the same measured approach with new products in the future.

Mobile Apps: A Fundamental Change In Trading

TD Ameritrade clients have quickly adopted mobile trading, with 40 percent of clients logging in daily on a mobile platform, said Steve Quirk, the executive vice president of the brokerage’s trading group.

Mobile trading has led to a “smoothing out” of trading volume, Quirk said: rather than almost all trading taking place at the market open and close, clients are interacting with the market throughout the day as news develops.

“It’s critical here,” Quirk said of the U.S. market. “In Asia, it’s amazing. They don’t even build anything on a web-based browser anymore.”

Roboadvising And Brokerages

TradeStation has had automated trading capabilities since the company was founded in 2001, said President John Bartleman.

A quant team is developing models for the company for a “hedge fund-type system” with artificial intelligence and machine learning technology, he said.

Quirk said the use of roboadvising technology is “less about the robo in and of itself” and more pertinent due to the way the technology will seep into other trader transactions.

Interactive Brokers purchased the company Covestor and has adopted robo technology for its adviser clientele, Sanders said.

Related Links: 

How The Largest Financial Institutions Innovate: 'How Do We Go And Disrupt Ourselves?'

Foursquare CEO Jeff Glueck Discusses The App's White Label Technology: 'We're Just Getting Started' 

Panel moderator Theresa Carey, left, with Charles Schwab's Barry Metzger, TD Ameritrade's Steve Quirk, Interactive Brokers' Steve Sanders and TradeStation President John Bartleman at the Benzinga Global Fintech Awards May 16, 2018 in New York City. Photo by Mandar Parab. 

Hot Value Stocks To Watch For 2018

On Wednesday, our Under the Radar Moversnewsletter suggested shorting small cap network equipment stock Ceragon Networks Ltd (NASDAQ: CRNT):

The Ceragon Networks short suggestion is a speculation that today’s bearish outside day can be taken at face value. By “outside day,” we just mean today’s open was above yesterday’s high, and today’s close (so far) is below yesterday’s low. The sudden swing in sentiment is telling, and with CRNT already overbought, it’s not difficult to believe the profit-takers are waiting in the wings. Today’s big swing back to bearishness suggests it’s begun.

Our Under the Radar Moversnewsletter has a detailed discussion about Ceragon Networks technical chart along with a shorting strategy:

Hot Value Stocks To Watch For 2018: Avangrid, Inc.(AGR)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    Avangrid Inc.(NYSE:AGR) Q1 2018 Earnings Conference CallApril 23, 2018 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Lisa Levin] Companies Reporting Before The Bell
    Kimberly-Clark Corporation (NYSE: KMB) is expected to report quarterly earnings at $1.71 per share on revenue of $4.60 billion.
    Halliburton Company (NYSE: HAL) is projected to report quarterly earnings at $0.42 per share on revenue of $5.75 billion.
    Lennox International Inc. (NYSE: LII) is estimated to report quarterly earnings at $1.09 per share on revenue of $815.16 million.
    Alaska Air Group, Inc. (NYSE: ALK) is projected to report quarterly loss at $0.12 per share on revenue of $1.82 billion.
    Hasbro, Inc. (NASDAQ: HAS) is expected to report quarterly earnings at $0.35 per share on revenue of $822.15 million.
    Lincoln Electric Holdings, Inc. (NASDAQ: LECO) is projected to report quarterly earnings at $1.08 per share on revenue of $729.83 million.
    Tennant Company (NYSE: TNC) is estimated to report quarterly earnings at $0.15 per share on revenue of $251.93 million.
    FirstEnergy Corp. (NYSE: FE) is projected to report quarterly earnings at $0.67 per share on revenue of $3.43 billion.
    Koninklijke Philips NV (ADR) (NYSE: PHG) is estimated to report earnings for its first quarter.
    Bank of Hawaii Corporation (NYSE: BOH) is expected to report quarterly earnings at $1.23 per share on revenue of $162.39 million.
    Avangrid, Inc. (NYSE: AGR) is projected to report quarterly earnings at $0.79 per share on revenue of $1.72 billion.

     

Hot Value Stocks To Watch For 2018: BioCryst Pharmaceuticals Inc.(BCRX)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on BioCryst Pharmaceuticals (BCRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on BioCryst Pharmaceuticals (BCRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Value Stocks To Watch For 2018: The Charles Schwab Corporation(SCHW)

Advisors’ Opinion:

  • [By ]

    Darn hard to not like the numbers out of Action Alerts PLUS holding JPMorgan & Chase (JPM) . Profits up nicely in all segments vs. the fourth quarter. Big year-over-year spikes in return on assets and equity from a year ago. Trading revenue up thanks to the return of volatility in the first quarter (can’t wait to see the blowout quarters from TD Ameritrade (AMTD) and Schwab (SCHW) ). Good card revenue growth from the fourth-quarter bodes well for retailer’s first-quarter results.

  • [By Joseph Griffin]

    TRADEMARK VIOLATION WARNING: “Credit Suisse Group Trims Charles Schwab (SCHW) Target Price to $60.00” was originally reported by Ticker Report and is the sole property of of Ticker Report. If you are viewing this piece on another domain, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be read at https://www.tickerreport.com/banking-finance/3356662/credit-suisse-group-trims-charles-schwab-schw-target-price-to-60-00.html.

  • [By Shane Hupp]

    Charles Schwab (NYSE:SCHW) had its target price cut by analysts at Credit Suisse Group from $62.00 to $61.00 in a research report issued on Monday. The firm presently has an “outperform” rating on the financial services provider’s stock. Credit Suisse Group’s price target would indicate a potential upside of 10.63% from the company’s current price.

Top 10 Stocks To Buy For 2018

Eldorado Resorts Inc (NASDAQ:ERI) files its latest 10-K with SEC for the fiscal year ended on December 31, 2017. Eldorado Resorts Inc is a gaming and hospitality company. It owns and operates gaming facilities located in Ohio, Louisiana, Nevada, Pennsylvania and West Virginia. Eldorado Resorts Inc has a market cap of $2.6 billion; its shares were traded at around $33.90 with a P/E ratio of 39.41 and P/S ratio of 1.74.

For the last quarter Eldorado Resorts Inc reported a revenue of $428.2 million, compared with the revenue of $206.5 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $1.5 billion, an increase of 65% from last year. For the last five years Eldorado Resorts Inc had an average revenue growth rate of 46.3% a year.

The reported diluted earnings per share was $1.09 for the year, an increase of 109.6% from previous year. The Eldorado Resorts Inc had an operating margin of 6.44%, compared with the operating margin of 9.98% a year before. The 10-year historical median operating margin of Eldorado Resorts Inc is 9.14%. The profitability rank of the company is 5 (out of 10).

Top 10 Stocks To Buy For 2018: Navios Maritime Partners LP(NMM)

Advisors’ Opinion:

  • [By Alex McGuire]

    These are the 10 best penny stocks that have seen the biggest returns over the last week (March 7 – March 14)…

    Penny StockCurrent PriceWeekly Gain (March 7 – March 14)Ocera Therapeutics Inc. (Nasdaq: OCRX)$1.47+147.1%Internap Corp. (Nasdaq: INAP)$3.28+41.4%Soligenix Inc. (Nasdaq: SNGX)$2.94+40%Navios Maritime Partners LP (NYSE: NMM)$2.63+37%QuickLogic Corp. (Nasdaq: QUIK)$2.14+30.5%Adamis Pharmaceuticals Corp. (Nasdaq: ADMP)$4.60+22.7EXCO Resources Inc. (NYSE: XCO)$0.65+20.5%Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC)$4.38+20.3%Hebron Technology Co. Ltd. (Nasdaq: HEBT)$3.99+19.1%Curis Inc. (Nasdaq: CRIS)$2.85+18.4%

    As a reminder, this is only a tracking metric of penny stocks trading on SEC-regulated exchanges like the Nasdaq and NYSE. Although these top penny stocks are safer than those trading on the pink sheets, we don’t recommend buying any of them without the proper amount of financial research.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Navios Maritime Partners (NMM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Elizabeth Balboa]

    Meanwhile, Safe Bulkers, Inc. (NYSE: SB) rose $0.73 throughout the 2016, Seanergy Maritime Holdings Corp. (NASDAQ: SHIP) fell $1.69 and Navios Maritime Partners L.P. (NYSE: NMM) dropped $0.93.

Top 10 Stocks To Buy For 2018: Apache Corporation(APA)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Cramer and the AAP team say news and caution are weighing on energy and health-care sectors. Find out what they’re telling their investment club members about Apache (APA) , Cimarex (XEC) , Arconic (ARNC) and Allergan (AGN) with a free trial subscription to Action Alerts PLUS.

  • [By VantagePoint]

    Apache Corporation (NYSE: APA) has been ripping since March 2nd, when it hit a two-year low of $33.60. Since then it's up 25 percent. 

    The three-month chart below shows that this trend is likely to continue. The blue line is generated via VantagePoint's intermarket analysis, and represents a prediction of what APA's moving average will be in three days. The black line is a simple 10-day moving average. Note the bullish crossover that occurred in early March. That was a signal that the stock was entering an uptrend. 

  • [By Chris Lange]

    Apache Corp. (NYSE: APA) fourth-quarter results are scheduled for Thursday. The consensus forecast is for $0.22 in EPS on $1.55 billion in revenue. Shares were trading at $38.11. The consensus price target is $50.43. The 52-week range is $35.70 to $56.51.

  • [By WWW.THESTREET.COM]

    Cramer and the Action Alerts PLUS team say they still believe in their embattled Permian names, Cimarex (XEC) and Apache (APA) , both of which have benefited from a slow rotation in recent weeks. These names can produce and profit here. Schlumberger (SLB) remains best in class and Magellan Midstream Partners just might be the best way to play oil given that the pipelines will be needed to transport the new wave of oil able to be drawn out of the ground from increasingly efficient American producers. Get in on the discussion by getting a free trial subscription to Action Alerts PLUS.

Top 10 Stocks To Buy For 2018: Ballard Power Systems, Inc.(BLDP)

Advisors’ Opinion:

  • [By Jim Robertson]

    With that in mind, I would add any stocks or sectors that benefit directly or indirectly from government subsidies because they are in cool or chosensectors that progressive liberal types worshipe.g. so called green or renewable energy or green technology plays like small capsBallard Power Systems Inc (NASDAQ: BLDP),FuelCell Energy Inc (NASDAQ: FCEL) and Plug Power Inc (NASDAQ: PLUG) along with solarinstallers Vivint Solar Inc (NYSE: VSLR) and Sunrun Inc (NASDAQ: RUN). Then there are thebigger and more globalsolar energy solutions stocks like First Solar, Inc (NASDAQ: FSLR) and SunPower Corporation (NASDAQ: SPWR) that will no doubt be the focus of any energy policy or global warming policy coming out of Washington.

  • [By Peter Graham]

    A long term performance chart shows shares of FuelCell Energy along withsmall cap alternative energy or fuel cell stocks like Ballard Power Systems Inc (NASDAQ: BLDP), Hydrogenics Corporation (NASDAQ: HYGS) and Plug Power Inc (NASDAQ: PLUG) all peaking in 2014 with some signs of stabilization early last yearalong withsome increase this year:

  • [By Lisa Levin]

    Friday afternoon, the non-cyclical consumer goods & services sector proved to be a source of strength for the market. Leading the sector was strength from Ballard Power Systems Inc. (USA) (NASDAQ: BLDP) and Sunoco LP (NYSE: SUN).

  • [By Lisa Levin]

    Thursday afternoon, the energy sector proved to be a source of strength for the market. Leading the sector was strength from Ballard Power Systems Inc. (USA) (NASDAQ: BLDP) and Sunoco LP (NYSE: SUN).

  • [By Peter Graham]

    Small cap fuel cell stock Ballard Power Systems Inc (NASDAQ: BLDP) reportedQ2 2017 earnings after the Wednesday market close as China is poised to lead the adoption of FCEVswith the Companycontinuing to focus on the execution of its China strategy during Q2.Revenuegrew 50% to$26.5 million reflecting growth in both Power Products and Technology Solutions. Power Products platform revenueincreased 29% to $15.2 million while the Technology Solutions platformrevenue increased 93% to$11.3 million primarily reflecting increased work on the stack joint venture, bus and tram programs in China. The net loss was $1.2 million foran improvement of $4.6 million or 79% and cash reserves were $68.1 million as of June 30 for an increase of 65% from the end of Q2 2016. The President/CEO commented:

  • [By Peter Graham]

    A long term performance chart shows shares of Plug Power along withalternative energy or fuel cell stock peers like Ballard Power Systems Inc (NASDAQ: BLDP), FuelCell Energy Inc (NASDAQ: FCEL) and Hydrogenics Corporation (NASDAQ: HYGS) all peaking in 2014 with shares leveling off or just sliding downward moderately over the past year:

Top 10 Stocks To Buy For 2018: EXCO Resources NL(XCO)

Advisors’ Opinion:

  • [By Alex McGuire]

    These are the 10 best penny stocks that have seen the biggest returns over the last week (March 7 – March 14)…

    Penny StockCurrent PriceWeekly Gain (March 7 – March 14)Ocera Therapeutics Inc. (Nasdaq: OCRX)$1.47+147.1%Internap Corp. (Nasdaq: INAP)$3.28+41.4%Soligenix Inc. (Nasdaq: SNGX)$2.94+40%Navios Maritime Partners LP (NYSE: NMM)$2.63+37%QuickLogic Corp. (Nasdaq: QUIK)$2.14+30.5%Adamis Pharmaceuticals Corp. (Nasdaq: ADMP)$4.60+22.7EXCO Resources Inc. (NYSE: XCO)$0.65+20.5%Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC)$4.38+20.3%Hebron Technology Co. Ltd. (Nasdaq: HEBT)$3.99+19.1%Curis Inc. (Nasdaq: CRIS)$2.85+18.4%

    As a reminder, this is only a tracking metric of penny stocks trading on SEC-regulated exchanges like the Nasdaq and NYSE. Although these top penny stocks are safer than those trading on the pink sheets, we don’t recommend buying any of them without the proper amount of financial research.

Top 10 Stocks To Buy For 2018: WildHorse Resource Development Corporation (WRD)

Advisors’ Opinion:

  • [By Paul Ausick]

    WildHorse Resource Development Corp. (NYSE: WRD) raised $413 million on the sale of $27.5 million at $15 per share, well below the expected range of $19 to $21. Shares popped just 0.4% for the day and closed the week down 0.9%.

Top 10 Stocks To Buy For 2018: Royal Bank Scotland plc (RBS)

Advisors’ Opinion:

  • [By Paul R. La Monica]

    European banks worse off than 2008? Lamensdorf is concerned about the exposure to bad loans (especially energy company debt) held by big banks such as Royal Bank of Scotland (RBS), Credit Suisse (CS) and Deutsche Bank (DB). He’s shorting all three.

  • [By Jonathan Morgan]

    Adidas AG slid 2.9 percent after lowering its profit forecast for 2013. Direct Line Insurance Group Plc lost 2.5 percent as Royal Bank of Scotland Group Plc (RBS) sold a 630 million-pound ($1 billion) stake in the U.K.s biggest car insurer.

  • [By Lisa Levin] Gainers
    ARMO BioSciences, Inc. (NASDAQ: ARMO) shares rose 67.5 percent to $49.96 in pre-market trading after Eli Lilly and Company (NYSE: LLY) announced plans to acquire ARMO BioSciences for $50 per share.
    Turtle Beach Corporation (NASDAQ: HEAR) rose 62.8 percent to $11.30 in pre-market trading after the company reported Q1 results and raised its FY18 outlook.
    vTv Therapeutics Inc. (NASDAQ: VTVT) rose 23.4 percent to $2.11 in pre-market trading following announcement that the company will pre-specify new subgroup with the FDA and report Phase 3 Part B results in June.
    Resonant Inc. (NASDAQ: RESN) rose 19.1 percent to $5.00 in pre-market trading after reporting Q1 results.
    RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 17.7 percent to $2.39 in pre-market trading following Q1 results.
    Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 15.2 percent to $2.20 in pre-market trading after French company Total announced plans to acquire 25 percent stake in Clean Energy Fuels for $83.4 million.
    Everspin Technologies, Inc. (NASDAQ: MRAM) rose 14.6 percent to $8.50 in pre-market trading after the company reported strong results for its first quarter.
    Carvana Co. (NYSE: CVNA) shares rose 11 percent to $27.50 in pre-market trading after reporting upbeat Q1 sales.
    Sunrun Inc. (NASDAQ: RUN) rose 8.9 percent to $10.70 in pre-market trading following upbeat quarterly earnings.
    MediciNova, Inc. (NASDAQ: MNOV) rose 8.1 percent to $11.35 in pre-market trading after the company announced opening of Investigational New Drug Application for MN-166 (ibudilast) in glioblastoma.
    New Gold Inc. (NYSE: NGD) shares rose 7.7 percent to $2.65 in pre-market trading after the company reported that its President and CEO Hannes Portmann left the company. The company named Raymond Threlkeld as successor.
    Otter Tail Corporation (NASDAQ: OTTR) shares rose 7.4 percent to $46.60 in the pre-market trading session.
    Himax Technologies, Inc. (NASDAQ: HIMX) shares rose

Top 10 Stocks To Buy For 2018: Kelly Services Inc.(KELYA)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Nomad Foods Limited (NYSE: NOMD) is estimated to report quarterly earnings at $0.36 per share on revenue of $656.43 million.
    AMC Networks Inc. (NASDAQ: AMCX) is expected to report quarterly earnings at $2.2 per share on revenue of $720.14 million.
    Magna International Inc. (NYSE: MGA) is projected to report quarterly earnings at $1.7 per share on revenue of $10.11 billion.
    Univar Inc. (NYSE: UNVR) is estimated to report quarterly earnings at $0.36 per share on revenue of $2.12 billion.
    Duke Energy Corporation (NYSE: DUK) is expected to report quarterly earnings at $1.14 per share on revenue of $5.78 billion.
    Owens & Minor, Inc. (NYSE: OMI) is projected to report quarterly earnings at $0.47 per share on revenue of $2.40 billion.
    Prestige Brands Holdings, Inc. (NYSE: PBH) is expected to report quarterly earnings at $0.61 per share on revenue of $255.60 million.
    Tribune Media Company (NYSE: TRCO) is projected to report quarterly earnings at $0.06 per share on revenue of $457.67 million.
    ArcBest Corporation (NASDAQ: ARCB) is estimated to report quarterly loss at $0.07 per share on revenue of $691.18 million.
    Genesis Healthcare, Inc. (NYSE: GEN) is projected to report quarterly loss at $0.34 per share on revenue of $1.32 billion.
    Enbridge Inc. (NYSE: ENB) is expected to report quarterly earnings at $0.55 per share on revenue of $10.14 billion.
    Kelly Services, Inc. (NASDAQ: KELYA) is estimated to report quarterly earnings at $0.42 per share on revenue of $1.34 billion.
    NICE Ltd. (NASDAQ: NICE) is expected to report quarterly earnings at $1.01 per share on revenue of $332.93 million.
    World Acceptance Corporation (NASDAQ: WRLD) is estimated to report quarterly earnings at $3.94 per share on revenue of $147.32 million.
    MAXIMUS, Inc. (NYSE: MMS) is expected to report quarterly earnings at $0.84 per share on revenue of $616.04 million.
    Choice Hotels International, Inc. (NYSE: CH
  • [By Monica Gerson]

    Kelly Services, Inc. (NASDAQ: KELYA) is projected to report its quarterly earnings at $0.28 per share on revenue of $1.35 billion.

    Silver Standard Resources Inc. (USA) (NASDAQ: SSRI) is expected to post a quarterly loss at $0.02 per share on revenue of $96.25 million.

  • [By David Milstead]

    One such outfit is Kelly Services (KELYA). The Troy, Mich., company places temporary employees in a variety of fields, such as law, health care, computing and finance. Although recent job reports have been strong, S&P Capital IQ analyst Michael Jaffe sees employers remaining cautious in their hiring practices and using the kind of temporary workers Kelly specializes in. Jaffe says Kelly is his top pick in the staffing sector, and he rates the stock a strong buy.

Top 10 Stocks To Buy For 2018: Mitsubishi Heavy Industries Ltd (MHVYF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Major foreign competitors today now include the French firm Areva (OTCPK:ARVCF) and the Japanese firm Mitsubishi Heavy Industry (OTCPK:MHVYF). This is not a complete list but a focus on major players.

Top 10 Stocks To Buy For 2018: Sage Therapeutics, Inc.(SAGE)

Advisors’ Opinion:

  • [By ]

    Cramer was bearish on Geron (GERN) , Mitek Systems (MITK) , AK Steel Holding (AKS) , Sage Therapeutics (SAGE) and AbbVie (ABBV) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By Chris Lange]

    Shares of Sage Therapeutics Inc. (NASDAQ: SAGE) saw an incredible gain on Thursday after the firm announced positive top-line results from its midstage trial. Specifically, the firm reported results from its Phase 2 trial of Sage-217 for the treatment of moderate to severe major depressive disorder (MDD).

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By WWW.THESTREET.COM]

    The Good

    The market remains resistant (Rs over Ss and Ns). Brokerages, banks and insurance companies continue their league-leading strength. The Russell 2000 Index is up for the 15th consecutive day. Retail extends yesterday’s strength. Nordstrom (JWN) , Macy’s (M) , Best Buy (BBY) , Target (TGT) , Walmart (WMT) , Foot Locker (FL) and JCPenney (JCP) are strong. First day down for Amazon (AMZN) . Agricultural commodities are lackluster, but soybeans are up another up $0.05 today, up substantially for three days in a row. Speculative biotech (Sage (SAGE) , FibroGen (FGEN) , Acadia Pharmaceuticals (ACAD) and Aerie Pharmaceuticals  (AERI) ) stronger after recent weakness. Ag equipment up big time after the Deere (DE) beat.

    The Bad

  • [By Dan Caplinger]

    Friday was a poor day on Wall Street, as the Dow Jones Industrials fell 200 points and other major benchmarks lost about 1%. Rising bond yields were a major source of consternation among those following the financial markets, with the 10-year Treasury hitting 2.95% and helping to send mortgage rates sharply higher. Even though earnings season has gone fairly well for many companies, some investors are also starting to realize that political issues are likely to cloud the outlook for the U.S. economy in the coming months, creating more uncertainty that could stymie further market gains. Some bad news affecting individual companies also added to the negative mood. Stanley Black & Decker (NYSE:SWK), ManpowerGroup (NYSE:MAN), and Sage Therapeutics (NASDAQ:SAGE) were among the worst performers on the day. Here’s why they did so poorly.

Top 10 Stocks To Buy For 2018: The Charles Schwab Corporation(SCHW)

Advisors’ Opinion:

  • [By Joseph Griffin]

    TRADEMARK VIOLATION WARNING: “Credit Suisse Group Trims Charles Schwab (SCHW) Target Price to $60.00” was originally reported by Ticker Report and is the sole property of of Ticker Report. If you are viewing this piece on another domain, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be read at https://www.tickerreport.com/banking-finance/3356662/credit-suisse-group-trims-charles-schwab-schw-target-price-to-60-00.html.

  • [By Taylor Cox]

    Analyst/Investor Days

    Equifax In Montreal
    LendingTree, Inc (NASDAQ: TREE)
    Iovance Biotherapeutics, Inc (NASDAQ: IOVA)
    The Charles Schwab Corporation (NYSE: SCHW) business update call

    Annual Shareholder Meetings

  • [By Lee Jackson]

    Charles Schwab Corp. (NYSE: SCHW) had a famous investor selling stock this past week. Chairman Charles Schwab continues to sell stock at an orderly pace. This week the iconic discount brokerage executive sold 600,000 shares at prices between $32.50 and $33.75. The total for the trade came to a whopping $20 million.As we have noted in the past, Schwab is past 80 years old and clearly much of his selling over the years has been for estate planning purposes. The shares traded Friday at $35.25, so a fair amount left on the table.

  • [By Shane Hupp]

    Charles Schwab (NYSE:SCHW) had its target price cut by analysts at Credit Suisse Group from $62.00 to $61.00 in a research report issued on Monday. The firm presently has an “outperform” rating on the financial services provider’s stock. Credit Suisse Group’s price target would indicate a potential upside of 10.63% from the company’s current price.

  • [By Jordan Wathen]

    It may not be obvious, but commission-free trades are more than just a marketing tool for discount brokers; they’re also a way to make money. Charles Schwab(NYSE:SCHW) charges asset managers a fee to make their ETFs and mutual funds commission free, collecting about $0.19 in annual fees for every $100 its clients invest in other companies’ ETFs and mutual funds. Last year, Schwab generated more income ($957 million) from offering such funds to its clients than it earned in commissions ($600 million) on trades its clients actually paid for!

  • [By Todd Shriber, ETF Professor]

    Vanguard's latest fee cuts answer two such moves this year, including one this month, by rival BlackRock, Inc. (NYSE: BLK) and one fee reduction announcement by Charles Schwab Corp (NYSE: SCHW).

Zurcher Kantonalbank Zurich Cantonalbank Grows Holdings in Charles Schwab Co. (SCHW)

Zurcher Kantonalbank Zurich Cantonalbank grew its position in Charles Schwab Co. (NYSE:SCHW) by 1.1% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 253,187 shares of the financial services provider’s stock after acquiring an additional 2,700 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Charles Schwab were worth $13,221,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also recently added to or reduced their stakes in SCHW. BlackRock Inc. increased its position in shares of Charles Schwab by 5.2% during the 4th quarter. BlackRock Inc. now owns 79,858,312 shares of the financial services provider’s stock valued at $4,102,323,000 after purchasing an additional 3,943,376 shares during the last quarter. Maverick Capital Ltd. bought a new position in shares of Charles Schwab during the 4th quarter valued at approximately $161,834,000. Amundi Pioneer Asset Management Inc. increased its position in shares of Charles Schwab by 40.7% during the 4th quarter. Amundi Pioneer Asset Management Inc. now owns 6,879,265 shares of the financial services provider’s stock valued at $353,386,000 after purchasing an additional 1,991,425 shares during the last quarter. WCM Investment Management CA increased its position in shares of Charles Schwab by 124.8% during the 4th quarter. WCM Investment Management CA now owns 2,207,060 shares of the financial services provider’s stock valued at $113,378,000 after purchasing an additional 1,225,146 shares during the last quarter. Finally, Element Capital Management LLC bought a new position in shares of Charles Schwab during the 4th quarter valued at approximately $47,239,000. 80.56% of the stock is currently owned by institutional investors and hedge funds.

Get Charles Schwab alerts:

Several equities analysts have recently weighed in on the company. Credit Suisse Group cut their target price on Charles Schwab from $70.00 to $69.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 7th. Jefferies Group restated a “buy” rating and set a $65.00 price objective on shares of Charles Schwab in a report on Friday, April 20th. SunTrust Banks restated a “buy” rating on shares of Charles Schwab in a report on Wednesday, February 14th. Citigroup cut Charles Schwab from a “neutral” rating to a “sell” rating and set a $49.00 price objective for the company. in a report on Wednesday, February 7th. Finally, Sanford C. Bernstein started coverage on Charles Schwab in a report on Monday, April 9th. They set a “market perform” rating and a $52.00 price objective for the company. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and ten have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $55.53.

Shares of SCHW stock opened at $56.97 on Tuesday. Charles Schwab Co. has a twelve month low of $37.63 and a twelve month high of $58.11. The firm has a market capitalization of $75.52 billion, a price-to-earnings ratio of 31.16, a PEG ratio of 2.01 and a beta of 1.56. The company has a debt-to-equity ratio of 0.30, a current ratio of 0.31 and a quick ratio of 0.30.

Charles Schwab (NYSE:SCHW) last issued its earnings results on Monday, April 16th. The financial services provider reported $0.55 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.54 by $0.01. Charles Schwab had a return on equity of 17.20% and a net margin of 28.80%. The business had revenue of $2.40 billion during the quarter, compared to analysts’ expectations of $2.38 billion. During the same period in the prior year, the business earned $0.39 EPS. The business’s revenue for the quarter was up 15.2% compared to the same quarter last year. equities analysts forecast that Charles Schwab Co. will post 2.42 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, May 25th. Shareholders of record on Friday, May 11th will be issued a $0.10 dividend. This represents a $0.40 annualized dividend and a dividend yield of 0.70%. The ex-dividend date is Thursday, May 10th. Charles Schwab’s dividend payout ratio is 24.39%.

In other Charles Schwab news, EVP Terri R. Kallsen sold 2,026 shares of the company’s stock in a transaction on Wednesday, February 7th. The stock was sold at an average price of $51.94, for a total value of $105,230.44. Following the completion of the sale, the executive vice president now directly owns 1,706 shares in the company, valued at approximately $88,609.64. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Jonathan M. Craig sold 2,629 shares of the business’s stock in a transaction on Monday, April 16th. The stock was sold at an average price of $52.11, for a total value of $136,997.19. The disclosure for this sale can be found here. Insiders sold a total of 1,622,977 shares of company stock valued at $89,966,897 over the last quarter. Company insiders own 11.50% of the company’s stock.

Charles Schwab Company Profile

The Charles Schwab Corporation, through its subsidiaries, provides wealth management, securities brokerage, banking, asset management, custody, and financial advisory services. The company operates through two segments, Investor Services and Advisor Services. The Investor Services segment provides retail brokerage and banking services, retirement plan services, and other corporate brokerage services; equity compensation plan sponsors full-service recordkeeping for stock plans, stock options, restricted stock, performance shares, and stock appreciation rights; and retail investor, retirement plan, and mutual fund clearing services.

Want to see what other hedge funds are holding SCHW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Charles Schwab Co. (NYSE:SCHW).

Institutional Ownership by Quarter for Charles Schwab (NYSE:SCHW)

Top 10 Blue Chip Stocks To Own Right Now

May 23, 2017: Markets opened higher again Tuesday but have not moved much higher as the session went on. The blue chips performed best with particular strength in financials. Tech stocks and consumer discretionaries are on track for a down finish. WTI crude oil for July delivery settled at $51.47 a barrel, up 0.7%. June gold dipped 0.5% for the day to settle at $1,255.60. Equities were headed for a mixed close shortly before the bell as the DJIA traded up 0.16% for the day, the S&P 500 traded up 0.14%, and the Nasdaq Composite traded down 0.01%.

The DJIA stock posting the largest daily percentage gain ahead of the close Tuesday was The Goldman Sachs Group Inc. (NYSE: GS) which traded up 1.75% at $219.80. The stock’s 52-week range is $138.20 to $3255.15. Volume was about 30% below the daily average of around 3.7 million shares. The company had no specific news Monday.

JPMorgan Chase & Co. (NYSE: JPM) traded up 1.28% at $85.78. The stock’s 52-week range is $57.05 to $93.98. Volume was about 40% below the daily average of around 14.8 million shares. The big bank had no specific news.

Top 10 Blue Chip Stocks To Own Right Now: Ebix, Inc.(EBIX)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap insurance software stock Ebix Inc (NASDAQ: EBIX) reported Q1 2017 earnings before the market opened this morning. Q1 revenue rose 11% to $79.1 million and decreased 1% over Q4 2016 revenue of $80.0 million. The year over year revenue improvement reflected growth in the Companys Exchange, Risk Compliance, and Broker Solution channels. On a constant currency basis, Q1 revenue increased 10% to $78.5 millionwith theExchange channel continued to bethe Companyslargest -accounting for 67% of Q1 2017 revenues. Q1 2017 net income rose 19% to $26.4 million with the improvement principally reflected the benefit of higher revenues and operating income as compared to the same period last year.

Top 10 Blue Chip Stocks To Own Right Now: 21Vianet Group, Inc.(VNET)

Advisors’ Opinion:

  • [By Leo Sun]

    In a previous article, I reviewed why GoPro, Twilio, and Wuba.com were all cut in half in 2016. Today I’ll add two Chinese tech stocks to that list — Renren (NYSE:RENN) and 21Vianet (NASDAQ:VNET) — which both lost more than half their value over the past 12 months.

  • [By Monica Gerson]

    21Vianet Group Inc (NASDAQ: VNET) shares rose 5.88 percent to $15.30 in the pre-market trading session as the company reported a $388 million investment by TUS Holdings.

Top 10 Blue Chip Stocks To Own Right Now: The Charles Schwab Corporation(SCHW)

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    Vanguard's latest fee cuts answer two such moves this year, including one this month, by rival BlackRock, Inc. (NYSE: BLK) and one fee reduction announcement by Charles Schwab Corp (NYSE: SCHW).

  • [By Garrett Baldwin]

    The ongoing trade rift between the United States and China continues to plague international markets. Despite reports that both countries are working behind the scenes to prevent additional detrimental trade policies, both countries recently proposed tens of billions in new tariffs on one another. The United States has accused China of widespread intellectual property theft, while China has accused the United States of unfair trade practices, including price manipulation in the agricultural industry. This morning, it’s worth noting that proposed tariffs on U.S. business jets will likely not provide a competitive advantage to foreign competition. Reuters reports that Chinese aviation executives do not see the layer of protectionism as a way to bolster the nation’s local market. Check back to Money Morning today for more insight on how the ongoing trade war could affect your investments.
    Finally, investors will continue to monitor ongoing developments in Washington around the presidency of Donald Trump. The White House has asked a federal judge to block prosecutors from reviewing any files seized from his lawyer’s office during a raid by the FBI last week. The agency seized a trove of documents from lawyer Michael Cohen’s office as part of an investigation into a payment of hush money. The spat between the White House and the FBI continues a day after former FBI Director James Comey called Trump “morally unfit to be president.”
    Three Stocks to Watch Today: BAC, NFLX, AAPL
    Shares of Bank of America Corp. (NYSE: BAC) added nearly 1% after the nation’s largest bank by deposits topped Wall Street earning expectations. The financial institution leads a busy day of earnings reports on Wall Street and hopes to keep its positive momentum from previous quarters. The firm reported earnings per share of $0.62 on top of $23.27 billion in revenue. That topped expectations of $0.59 on top of $22.91 billion thanks to strong growth in its consumer loan business and the r

  • [By Lee Jackson]

    Charles Schwab Corp. (NYSE: SCHW) also had a famous investor selling stock this past week. The chairman of the company, Charles Schwab, continues to sell stock at an orderly pace. This week the iconic discount brokerage executive and the CEO of the company combined to sell a block of 400,000 shares at prices between $35.43 and $35.46. The total for the trades came to a whopping $14 million.As we have noted in the past, Mr. Schwab is past 80 years old, and clearly much of his selling over the years has been for estate planning purposes. The shares endedFriday at $37.48 so a fair amount left on the table.

  • [By Lee Jackson]

    Charles Schwab Corp. (NYSE: SCHW) had a famous investor selling stock this past week. Chairman Charles Schwab continues to sell stock at an orderly pace. This week the iconic discount brokerage executive sold 600,000 shares at prices between $32.50 and $33.75. The total for the trade came to a whopping $20 million.As we have noted in the past, Schwab is past 80 years old and clearly much of his selling over the years has been for estate planning purposes. The shares traded Friday at $35.25, so a fair amount left on the table.

  • [By Tyler Crowe, Tim Brugger, and Jordan Wathen]

    With that in mind, we asked three of our contributors to highlight a company they will be following closely in the first quarter and why. Here’s what makes Adobe Systems (NASDAQ:ADBE), Charles Schwab (NYSE:SCHW), and U.S. Silica Holdings (NYSE:SLCA) worth following when the next earnings report comes out.

  • [By ]

    Darn hard to not like the numbers out of Action Alerts PLUS holding JPMorgan & Chase (JPM) . Profits up nicely in all segments vs. the fourth quarter. Big year-over-year spikes in return on assets and equity from a year ago. Trading revenue up thanks to the return of volatility in the first quarter (can’t wait to see the blowout quarters from TD Ameritrade (AMTD) and Schwab (SCHW) ). Good card revenue growth from the fourth-quarter bodes well for retailer’s first-quarter results.

Top 10 Blue Chip Stocks To Own Right Now: Biotricity (BTCY)

Advisors’ Opinion:

  • [By James E. Brumley]

    When an investor thinks of stocks in the cardio-monitoring arena, names like General Electric Company (NYSE:GE) and Medtronic PLC (NYSE:MDT) tend to surface first. And well they should. Medtronic is the largest name dedicated solely to equipment that tells doctors and nurses how well a patient’s heart is functioning, while GE Healthcare smartly leverages the name of its parent company’s recognizable name to win market share in the medical equipment space.

    General Electric and Medtronic aren’t the only names in town, however, and certainly not the top prospects for an investor seeking out a fresh, undiscovered growth opportunity. That honor arguably belongs to an up-and-coming small cap outfit called Biotricity Inc. (OTCMKTS:BTCY), which is nearing its first-ever revenue.

    Don’t look for a Biotricity product quite yet, as they’re not on the market. Consumers as well as investors will want to keep their eyes and ears open for two of them soon though, however, with one of those devices being a high-precision, FDA-approved instrument for use by healthcare workers in a clinical setting. The other device is a consumer-oriented version of the same technology, giving BTCY access to not just one but two crucial markets. Even more recently Biotricity reported it was opening up its development pipeline to the fetal monitoring and sleep apnea markets. Heart-monitoring is the near-term venture, though.

    The two products are called biotricity and biolife (neither moniker is supposed to be capitalized). The latter is a wireless, remote consumer-oriented heart rate and activity monitoring device, and the former is a clinical-grade monitoring device… also wireless and remotely operated/monitored.

    Bioflux is only available by prescription. The bioflux hardware includes an ECG (heart-rhythm) monitoring device, software, and if desired, service from a monitoring lab that performs remote diagnostic monitoring for up to 30 consecutive days at a time. It

  • [By Robert J. Smith]

    Biotricity (OTCBB: BTCY) is a comer in the rapidly growing medical device market and is a small cap to take notice of. Driving this lucrative market are; IoT-driven device connectivity, governmental pressure to cut healthcare costs, escalating hospital costs, a need to reduce hospital readmission rates, an aging population, and a high rate of people with chronic disease. The largest factor driving this market is the rapidly growing rate of those afflicted with chronic disease.

  • [By James E. Brumley]

    When an investor thinks of stocks in the cardio-monitoring arena, names like General Electric Company (NYSE:GE) and Medtronic PLC (NYSE:MDT) tend to surface first. And well they should. Medtronic is the largest name dedicated solely to equipment that tells doctors and nurses how well a patient’s heart is functioning, while GE Healthcare smartly leverages the name of its parent company’s recognizable name to win market share in the medical equipment space.

    General Electric and Medtronic aren’t the only names in town, however, and certainly not the top prospects for an investor seeking out a fresh, undiscovered growth opportunity. That honor arguably belongs to an up-and-coming small cap outfit called Biotricity Inc. (OTCMKTS:BTCY), which is nearing its first-ever revenue.

    Don’t look for a Biotricity product quite yet, as they’re not on the market. Consumers as well as investors will want to keep their eyes and ears open for two of them soon though, however, with one of those devices being a high-precision, FDA-approved instrument for use by healthcare workers in a clinical setting. The other device is a consumer-oriented version of the same technology, giving BTCY access to not just one but two crucial markets. Even more recently Biotricity reported it was opening up its development pipeline to the fetal monitoring and sleep apnea markets. Heart-monitoring is the near-term venture, though.

    The two products are called biotricity and biolife (neither moniker is supposed to be capitalized). The latter is a wireless, remote consumer-oriented heart rate and activity monitoring device, and the former is a clinical-grade monitoring device… also wireless and remotely operated/monitored.

    Bioflux is only available by prescription. The bioflux hardware includes an ECG (heart-rhythm) monitoring device, software, and if desired, service from a monitoring lab that performs remote diagnostic monitoring for up to 30 consecutive days at a time. It

  • [By Peter Graham]

    On the other hand, small cap wearables stock Biotricity (OTCQB: BTCY)is a different wearables play as theCompanys mission is to revolutionize chronic care management by developing innovative solutions that bridge the gap between diagnostic care and disease management. A medical technology company, Biotricity is focused on delivering innovative, remote biometric monitoring solutions to the healthcare and consumer markets, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. Biotricitys R&D continues to focus on the preventative healthcare market, with a vision of putting health management into the hands of the individual. The Company aims to support the self-management of critical and chronic conditions with the use of innovative solutions to ease the growing burden on the healthcare system.

Top 10 Blue Chip Stocks To Own Right Now: HealthEquity, Inc.(HQY)

Advisors’ Opinion:

  • [By Lee Jackson]

    These companies also reported insider buying last week: Cidara Therapeutics Inc. (NASDAQ: CDTX), Ducommun Inc. (NYSE: DCO), HealthEquity Inc. (NASDAQ: HQY), Panhandle Oil and Gas Inc. (NYSE: PHX) and PolarityTE Inc. (NASDAQ: COOL).

Top 10 Blue Chip Stocks To Own Right Now: Coca-Cola Bottling Co. Consolidated(COKE)

Advisors’ Opinion:

  • [By Douglas A. McIntyre]

    Coca-Cola Bottling Co. (NYSE: COKE) had a revenue increase to $2.3 billion in its most recentfiscal year, from $1.7 billion in the previous one. It is moving into Ohio, Indiana, Kentucky, Illinois and West Virginia, which almost certainly will require capital. Its net sales rose 37% in the most recent quarter to $840 million. Management stated this was because of “Organic growth in the legacy territories as well as territory expansion through the acquisition of several new distribution territories from Coca-Cola led to the solid performance.” The current dividend is $1, or 0.66%.

Top 10 Blue Chip Stocks To Own Right Now: Glaukos Corporation(GKOS)

Advisors’ Opinion:

  • [By Nelson Hem]

    In "Skeptics Eye Potential Trouble for Glaukos," Vito J. Racanelli suggests that, even though Glaukos Corp (NYSE: GKOS) has warned that it might lose money this year, Wall Street appears to be betting otherwise. This eye-stent maker has had success with a breakthrough product and dominates its market, but formidable competition still looms.

Top 10 Blue Chip Stocks To Own Right Now: Zillow Group, Inc.(ZG)

Advisors’ Opinion:

  • [By Steve Symington]

    The stock market was mostly flat today ahead of a key House vote on the passage of the Republicans’ healthcare bill, which was delayed until Friday after GOP lawmakers failed to gather the necessary support. TheDow Jones Industrial Averagelost just 5 points, or 0.02%, while other broader market indexes saw similar small declines. But several individual stocks saw much more severe drops, including Zillow Group (NASDAQ:Z) (NASDAQ:ZG), Proofpoint (NASDAQ:PFPT), and Accenture (NYSE:ACN). Read on to see what drove these unusual moves.

  • [By Steve Symington]

    Shares of Zillow Group Inc. (NASDAQ:Z)(NASDAQ:ZG)climbed 13.8% in the month of April,according to data provided byS&P Global Market Intelligence, ahead of the online real estate specialist’s impending first-quarter 2017 report.

Top 10 Blue Chip Stocks To Own Right Now: Varex Imaging Corporation (VREX)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Varex Imaging (VREX), a stock that wasn’t even in the index yesterday, soared to the top of the S&P 500 today after being spun out of Varian Medical Systems (VAR).

    Agence France-Presse/Getty Images

    Varex Imaging gained 7.3% to $27.27 today, while the S&P 500 declined 0.6% to2,280.90. Varian Medical Systems fell 1.2% to $77.68.

    Varian Medical Systems reported net income of $402 million on sales of $3.2 billion in 2016.

  • [By Jim Robertson]

    Small cap homeland security and screening stocks like FLIR Systems (NASDAQ: FLIR), OSI Systems (NASDAQ: OSIS),Varex Imaging Corp (NASDAQ: VREX) and Patriot One Technologies (OTCQB: PTOTF) stand to benefit fromTrumps focus on border andinternal security in general. Heres what you need to know about all four:

Top 10 Blue Chip Stocks To Own Right Now: Nordstrom Inc.(JWN)

Advisors’ Opinion:

  • [By Douglas A. McIntyre]

    The mall was created by accident, in some ways. Downtown Bloomington, Minnesota, lost its two largest corporate residents in 1982, football’s Minnesota Vikings and baseball’s Minnesota Twins. Over 78 acres became available for development. After debates about what should happen to the land, local officials decided to give it to financiers who wanted to build America’s largest home for retailers. It opened in 1992, two years before Amazon.com Inc. (NASDAQ: AMZN) was founded. Early tenants included Macy’s Inc. (NYSE: M), the Sears division of Sears Holdings Corp. (NASDAQ: SHLD) and Nordstrom Inc. (NYSE: JWN). All three have been injured by the current downturn in traditional retail sales.

  • [By ]

    Some reasons for my bearishness on retail stocks:

    Higher Energy Prices. Oil prices have rallied dramatically and back to 2014 levels, rising from about $35 a barrel in early 2016 to around $67 Thursday. That’s bad news for U.S. retailers, as rising oil prices historically squeeze consumer disposable incomes. That’s one reason why I’ve been consistently raising my short exposure to retail and plan to continue doing so. Shaky Same-Store Sales Growth. Recent improvements to same-store sales at Abercrombie & Fitch (ANF) , Urban Outfitters (URBN) , Dillard’s (DDS) , Gap Inc. (GPS) and Macy’s (M) come against downgraded expectations, and might not be sustainable anyway. No Deal for Nordstrom (JWN) . The Nordstrom family has apparently abandoned plans to take its namesake company private. I had expressed concerns that this would happen. Higher Interest Rates. A rise in the London Inter-Bank Offered Rate (LIBOR) has recently accelerated. That’s bad news for retailers, as many variable-rate consumer debts (particularly mortgages) key off of the LIBOR. This will likely put a damper on mortgage refinancings — something that many see as an important ingredient for personal-consumption expenditures.

  • [By Rich Duprey]

    An increasing number of retailers have announced their intention to drop Ivanka Trump’s merchandise line. From Nordstrom (NYSE:JWN) and Belk to Neiman-Marcus and Burlington, there’s a growing movement for retailers to distance themselves from the Trump brand.

  • [By Chris Lange]

    Look for Nordstrom Inc. (NYSE: JWN) to reveal its fiscal second-quarter results on Thursday as well. The consensus analyst estimates are $0.63 in EPS and revenue of $3.74 billion. Shares of Nordstrom closed at $46.81 on Friday, above the consensus price target of $46.00. The 52-week range is $39.53 to $62.82.

Credit Suisse Group Trims Charles Schwab (SCHW) Target Price to $60.00

Charles Schwab (NYSE:SCHW) had its price objective lowered by Credit Suisse Group from $69.00 to $60.00 in a research note published on Wednesday morning. The brokerage currently has an outperform rating on the financial services provider’s stock.

Other equities analysts have also issued reports about the company. Morgan Stanley increased their price target on Charles Schwab from $63.00 to $65.00 and gave the company an overweight rating in a research note on Tuesday. Deutsche Bank decreased their price target on Charles Schwab from $55.00 to $54.00 and set a hold rating for the company in a research note on Friday, April 6th. Sanford C. Bernstein assumed coverage on Charles Schwab in a research note on Monday, April 9th. They set a market perform rating and a $52.00 price target for the company. Wells Fargo reaffirmed a market perform rating and set a $55.00 price target (up from $47.00) on shares of Charles Schwab in a research note on Thursday, January 4th. Finally, Zacks Investment Research lowered Charles Schwab from a buy rating to a hold rating in a research note on Tuesday, March 6th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and nine have issued a buy rating to the company. Charles Schwab has an average rating of Hold and an average price target of $54.47.

How to Become a New Pot Stock Millionaire

Shares of SCHW stock opened at $51.04 on Wednesday. Charles Schwab has a 12-month low of $37.16 and a 12-month high of $58.11. The company has a market capitalization of $68,562.40, a P/E ratio of 31.12, a price-to-earnings-growth ratio of 1.25 and a beta of 1.55. The company has a debt-to-equity ratio of 0.30, a current ratio of 0.31 and a quick ratio of 0.30.

Charles Schwab (NYSE:SCHW) last issued its quarterly earnings data on Wednesday, January 17th. The financial services provider reported $0.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.41 by $0.03. Charles Schwab had a return on equity of 16.03% and a net margin of 27.32%. The business had revenue of $2.24 billion during the quarter, compared to analyst estimates of $2.24 billion. During the same period in the prior year, the company posted $0.36 EPS. The business’s revenue for the quarter was up 13.7% compared to the same quarter last year. equities research analysts forecast that Charles Schwab will post 2.4 EPS for the current fiscal year.

In other news, EVP Terri R. Kallsen sold 2,026 shares of the stock in a transaction on Wednesday, February 7th. The stock was sold at an average price of $51.94, for a total transaction of $105,230.44. Following the completion of the sale, the executive vice president now owns 1,706 shares in the company, valued at approximately $88,609.64. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Jonathan M. Craig sold 5,000 shares of the stock in a transaction on Monday, March 12th. The shares were sold at an average price of $58.01, for a total value of $290,050.00. The disclosure for this sale can be found here. Insiders have sold a total of 920,225 shares of company stock valued at $50,239,974 in the last quarter. Insiders own 11.50% of the company’s stock.

Large investors have recently made changes to their positions in the company. Bank of The West lifted its position in shares of Charles Schwab by 1.9% during the 4th quarter. Bank of The West now owns 105,131 shares of the financial services provider’s stock valued at $5,400,000 after acquiring an additional 1,948 shares during the last quarter. Atria Investments LLC lifted its holdings in shares of Charles Schwab by 11.8% in the fourth quarter. Atria Investments LLC now owns 18,096 shares of the financial services provider’s stock valued at $930,000 after purchasing an additional 1,907 shares in the last quarter. State of Alaska Department of Revenue lifted its holdings in shares of Charles Schwab by 311.7% in the fourth quarter. State of Alaska Department of Revenue now owns 141,615 shares of the financial services provider’s stock valued at $7,272,000 after purchasing an additional 107,221 shares in the last quarter. Peregrine Asset Advisers Inc. purchased a new stake in shares of Charles Schwab in the fourth quarter valued at $5,306,000. Finally, Aviance Capital Partners LLC lifted its holdings in shares of Charles Schwab by 52.1% in the fourth quarter. Aviance Capital Partners LLC now owns 59,944 shares of the financial services provider’s stock valued at $3,079,000 after purchasing an additional 20,531 shares in the last quarter. Institutional investors own 80.56% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Credit Suisse Group Trims Charles Schwab (SCHW) Target Price to $60.00” was originally reported by Ticker Report and is the sole property of of Ticker Report. If you are viewing this piece on another domain, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be read at https://www.tickerreport.com/banking-finance/3356662/credit-suisse-group-trims-charles-schwab-schw-target-price-to-60-00.html.

About Charles Schwab

The Charles Schwab Corporation, through its subsidiaries, provides wealth management, securities brokerage, banking, asset management, custody, and financial advisory services. The company operates through two segments, Investor Services and Advisor Services. The Investor Services segment provides retail brokerage and banking services, retirement plan services, and other corporate brokerage services; equity compensation plan sponsors full-service recordkeeping for stock plans, stock options, restricted stock, performance shares, and stock appreciation rights; and retail investor, retirement plan, and mutual fund clearing services.

Analyst Recommendations for Charles Schwab (NYSE:SCHW)

Top 5 Industrial Disributor Stocks To Buy Right Now

Stocks fell the most since February as investors decided that maybe the market had come too far than justified by fundamentals.

Michael Nagle/Bloomberg News

The S&P 500 rose 1.2% to 2,041.91 today, its biggest decline since Feb. 23, while the Dow Jones Industrial Average fell 174.09 points, or 1%, to 17,541.96. The Nasdaq Composite tumbled 1.5% to4848.37, its biggest drop since Feb. 8

The only news today was good news: U.S. jobless claims fell to 267,000, below forecasts for 268,000, and the 57th straight week that claims remained below 300,000.

So why is the market slipping? JPMorgan’sDubravko Lakos-Bujas blames “technical factors having already run their course.” He explains:

The market has weathered one of the most volatile first quarters in recent years. Since February lows recession fears appear to have faded, with the US market rallying 13% since then, the forward equity multiple re-rating back to its 2015 highs of ~17.5x, and the VIX back below 14. We think this recovery has been largely driven by fundamentally insensitive strategies and broad based short covering. Our high-frequency Utilization Ratio for stocks and ETFs has almost fully normalized to pre sell-off levels, implying little room left for further short covering. Positioning wise, trend-following strategies (CTAs) have covered most of their shorts and are currently close to being neutral equities. Risk parity portfolios and macro funds are long equities with their exposure approaching levels seen late last year. Long/short equity strategies exposures remain above average levels, and if anything have started to come off their mid March highs. With most of the technical factors h aving already run their course and with equity valuation at elevated levels, we believe a re-acceleration in earnings growth and weaker USD are needed to warrant a more constructive view on US equities.

Top 5 Industrial Disributor Stocks To Buy Right Now: Smithfield Foods Inc.(SFD)

Smithfield Foods, Inc., together with its subsidiaries, engages in the production and marketing of fresh meat and packaged meats products in the United States and internationally. The company involves in the production of hog; and produces various fresh pork, beef, poultry, and packaged meats products. It sells fresh pork to retail customers as unprocessed and trimmed cuts, such as butts, loins, picnics, and ribs; packaged meats products, including smoked and boiled hams, bacon, sausage, hot dogs, and deli and luncheon meats; specialty products, such as pepperoni and dry meat products; and ready-to-eat prepared foods comprising pre-cooked entrees, and pre-cooked bacon and sausages. The company offers its products to supermarket chains; wholesale distributors; the foodservice industry, including fast food, restaurant and hotel chains, hospitals, and other institutional customers; export markets; and other further processors. It sells its products through its salespersons an d independent commission brokers. Smithfield Foods, Inc. was founded in 1961 and is headquartered in Smithfield, Virginia.

Advisors’ Opinion:

  • [By Victor Mora]

    Smithfield Foods is a provider of fresh and packaged meat products that are seen as a staple food item for many consumers and growing populations worldwide. A takeover of the company is believed to be going through after a shareholder vote scheduled for Tuesday. The stock has been moving higher in recent years and is now trading slightly below all-time high prices. Over the last four quarters, investors have had mixed feelings about the company, as earnings have been decreasing and revenues have been rising. Relative to its peers and sector, Smithfield Foods has been a year-to-date performance leader. WAIT AND SEE if a vote to acquire Smithfield Foods goes through.

Top 5 Industrial Disributor Stocks To Buy Right Now: Apollo Global Management, LLC(APO)

 

Apollo Global Management, LLC is a publicly owned investment manager. It primarily provides its services to endowment and sovereign wealth funds, as well as other institutional and individual investors. The firm manages client focused portfolios. It launches and manages hedge funds and mutual funds for its clients. The firm also manages real estate funds and private equity funds for its clients. The firm invests in the fixed income and alternative investment markets across the globe. Its alternative investments include investment in private equity and real estate markets. The firm’s private equity investments include traditional buyouts, recapitalization, distressed buyouts and debt investments in real estate, corporate partner buyouts, distressed asset, corporate carve-outs, turnaround, corporate restructuring, special situation, acquisition, and industry consolidation transactions. Its fixed income investments include income -oriented senior loan and bond, structured credit, opportunistic credit, non-performing loans and value oriented fixed income securities. The firm seeks to invest in chemicals; commodities; consumer and retail; oil and gas, metals, mining, agriculture, commodities, distribution and transportation; financial and business services; manufacturing and industrial; media distribution, cable, entertainment, and leisure; natural resources, energy, packaging and materials; and satellite and wireless. It seeks to invest in companies based in across North America with a focus on United States, and Europe. The firm also makes investments outside North America, primarily in Western Europe and Asia. The firm employs a combination of contrarian, value, and distressed strategies to make its investments. It conducts an in-house research to create its investment portfolio. The firm seeks to acquire minority positions in its portfolio companies. The firm seeks to make investments in the range of $200 million and $1.5 billion. Apollo Global Management, ! LLC was founded in 1990 and is headquartered in New York, New York with additional offices in Los Angeles, California; Purchase, New York; Houston, Texas; London, United Kingdom; Frankfurt, Germany; Luxembourg, Luxembourg; Hong Kong, Hong Kong; Singapore, Singapore; and Mumbai, India.

Advisors’ Opinion:

  • [By Lisa Levin]

    The Fresh Market Inc (NASDAQ: TFM) agreed be acquired by Apollo Global Management LLC (NYSE: APO) for $28.50 per share in cash.

    In an approximately $1.4 billion in cash buyout, shareholders are set to receive $28.50 per share. This calculates to an approximately 53 percent premium over the February 10 closing price and an approximately 24 percent premium over last Friday’s closing price.

  • [By Chad Tracy]

    In 2008, Apollo Global Management (NYSE: APO) co-founder Joshua Harris was on a losing streak.

    The firm's $430 million investment in big-box retailer Linens N' Things went south when the company filed for bankruptcy.

Top 10 Gas Stocks To Own Right Now: Pinnacle West Capital Corporation(PNW)

Pinnacle West Capital Corporation, through its subsidiaries, provides retail and wholesale electric services primarily in the State of Arizona. The company involves in the generation, transmission, and distribution of electricity through coal, nuclear, gas and oil, and solar resources. It also offers energy-related products and services, such as energy master planning, energy use consultation and facility audits, cogeneration analysis and installation, and project management with a focus on energy efficiency and renewable energy to commercial and industrial retail customers in the western United States. In addition, the company owns minority interests in various energy-related investments and Arizona community-based ventures; and develops residential, commercial, and industrial real estate projects in Arizona, Idaho, New Mexico, and Utah. As of December 31, 2010, it owned or leased approximately 6,290 mega watts of regulated generation capacity; and serviced approximately 1.1 million customers. Pinnacle West Capital Corporation was founded in 1920 and is based in Phoenix, Arizona.

Advisors’ Opinion:

  • [By Ben Levisohn]

    Iron Mountain has gained 2.6% to $26.55 at 3:05 p.m., making it the fourth-best performer in the S&P 500, ahead of WPX Energy (WPX), which has gained 2.4% to $19.94, Pinnacle West Capital (PNW), which has gained 2.3% to $53.55 and Dominion Resources (D), which has risen 2.1% to $59.85.

Top 5 Industrial Disributor Stocks To Buy Right Now: The Charles Schwab Corporation(SCHW)

 

The Charles Schwab Corporation, through its subsidiaries, provides wealth management, securities brokerage, banking, money management, and financial advisory services. The company operates through two segments, Investor Services and Advisor Services. It offers brokerage products, such as brokerage accounts; individual retirement accounts; retirement plans for small to large businesses; 529 college savings accounts; designated brokerage accounts; equity incentive plan accounts; and margin loans, as well as access to fixed income securities, equity and debt offerings, options, and futures. The company also provides no-load, proprietary, and other third-party mutual funds, as well as mutual fund trading and clearing services to broker-dealers; and third-party and proprietary exchange-traded funds. In addition, it offers advice solutions, including separately managed accounts, customized personal advice for tailored portfolios, an d specialized planning and full-time portfolio management; and trust custody services, personal trust reporting services, and administrative trustee services. Further, the company provides banking products, such as checking accounts linked to brokerage accounts, savings accounts, certificates of deposit, demand deposit accounts, first lien residential real estate mortgage loans, home equity loans and lines of credit, and personal loans and entity lending collateralized by securities. It serves individuals and institutional clients in the United States, the Commonwealth of Puerto Rico, London, and Hong Kong. The Charles Schwab Corporation was founded in 1971 and is headquartered in San Francisco, California.

Advisors’ Opinion:

  • [By Javier Hasse]

    The other big earnings call of the day was that of Charles Schwab Corp (NYSE: SCHW), which delivered in-line first quarter EPS of $0.29, on revenue of $1.76 billion, which beat estimates by $10 million.

  • [By Matthew Smith]

    Although we were not surprised by the move yesterday we did not take an overly aggressive stance in positioning the portfolio to benefit from the Fed not tapering. We were long, but we did not initiate any trades solely for the purpose to benefit from the announcement. We are more interested in the long-term wealth building of portfolios right now and as such believe that readers should look to our recent winners that had pullbacks yesterday as buying opportunities. Specifically, we like Ameritrade (AMTD), Charles Schwab (SCHW) and MetLife (MET) which all saw pullbacks ranging from 2.5% to a bit over 5.5% in yesterday’s session. We highlighted the discount brokers as a sector to watch right before the latest takeoff and our belief is that although rates remain unchanged the brokerage business will continue to perform strongly. The next big move up will be as rates rise, but even if one has to wait for this move it will be well worth it for one’s portfolio.

Top 5 Industrial Disributor Stocks To Buy Right Now: Regeneron Pharmaceuticals, Inc.(REGN)

 

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. Its marketed products include EYLEA injection for the treatment of neovascular age-related macular degeneration (AMD) and macular edema; ZALTRAP, an injection for intravenous infusion for the treatment of patients with metastatic colorectal cancer; and ARCALYST, an injection for subcutaneous use for the treatment of cryopyrin-associated periodic syndromes comprising familial cold auto-inflammatory syndrome and muckle-wells syndrome in adults and children. The companys trap-based clinical product candidates comprise EYLEA for the treatment of AMD and diabetic macular edema; and ZALTRAP for oncology. Its antibody-based clinical programs include various human monoclonal antibody product candidates, such as REGN727 for low-density lipopro tein cholesterol reduction and for the prevention of cardiovascular events; REGN88 for rheumatoid arthritis and non-infectious uveitis; REGN668 for atopic dermatitis, asthma, nasal polyposis, and eosinophilic esophagitis; REGN2222 for respiratory syncytial virus; REGN1033 for skeletal muscle disorders; and REGN2176-3 and REGN910-3 antibodies for use in ophthalmology. The company is also developing REGN1908-1909, REGN1154, REGN1500, and REGN1193 antibody product candidates; REGN1400, REGN1979, and REGN2810 for oncology; and REGN475 for the treatment of pain. It has collaborations with Sanofi and Mitsubishi Tanabe Pharma Corporation; license and collaboration agreement with Bayer HealthCare; and Avalanche Biotechnologies, Inc., as well as Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services. The company was founded in 1988 and is headquartered in Tarrytown, New York.

Advisors’ Opinion:

  • [By Ben Levisohn]

    BMO’s M. Ian Somaiya and team contend biotech stocks like Gilead Sciences (GILD) Amgen (REGN), Celgene (CELG) and Regeneron (REGN) might be bottoming–but that a bounce back probably won’t happen until the second half of the year. They explain why:

  • [By Ben Levisohn]

    Do we need to remind you how hard biotech stocks have been hit this year? If you read this blog, probably not, but we’ll do it anyway. The iShares Nasdaq Biotechnology ETF (IBB) has fallen 24%, while Gilead Sciences (GILD) has declined 8.7%, Biogen (BIIB) has fallen 17%, Celgene (CELG) has dropped 16%, and Regeneron Pharmaceuticals (REGN) has plunged 32%. Yet despite these drops–and the decline in valuation that accompanied them–the Janus Equity Team contends nothing has changed for the sector:

  • [By Ben Levisohn]

    Biotech stocksRegeneron Pharmaceuticals (REGN),Biogen (BIIB),Amgen (AMGN) and Celgene (CELG), among themhave staged nice rallies during the past three months but are still down for 2016. Now, Piper Jaffray’s Joshua Schimmer and team ask: “What’s the trade for the rest of the year?” They answer their own question:

    Reuters

    Investors are generally lukewarm on biopharma, and many think we’re finally moving towards a ‘stock-pickers’ environment and away from the group trade that has dominated for much of the past year. Some valuations are viewed as more attractive than others, but with few obvious shorts to be found. Much discussion is on M&A target.

    Large cap focus: Investors are generally sticking to more liquid names, although we are slowly seeing a return of interest to select small-caps. The general agreement is that fundamentals have changed, biopharma pricing power has eroded, payors/PBMs are wielding considerable power and more uncertainty exists for product outlooks.

    Gilead Sciences’ (GILD) 7x P/E plus potential to engineer some form of EPS CAGR seems to resonate strongly with investors despite lingering questions on the HCV franchise and underwhelming pipeline, but the HIV franchise and Genvoya launch appear to be in good shape with potential to finally drive the kind of earnings beats that can drive shares higher in our view.

    Most investors seeBiogen as a company that has deteriorated in quality but offers very attractive valuation optionality around LINGO (despite low expectations), Alzheimer’s (readthrough from Solanezumab), and they see a theoretically strategic fit with Roche (aligned on the CD20 and MS franchises). Many felt that a likely large bid/ask spread over the value of the Alzheimer’s program may be difficult to reconcile should there be real interest there. Investors are also wondering if the hemophilia spin is actually in response to

  • [By Ben Levisohn]

    Regeneron Pharmaceuticals (REGN) lost a patent case with Amgen (AMGN) and now a judge will have to make a decision regarding an injunction on sales of Praluent. Citigroup’s Robyn Karnauskas and Mohit Bansal provide and update:

    We spoke to Regeneron regarding the timelines of the injunction decision in the PCSK9 patent case and the company noted that the Judges opinion could come in 3-4 months. The hearing on injunction took place last week and the Judge now will have to form an opinion based on the hearing. This typically takes 3-4 months to get the opinion per the company.

    This makes Dupilumab phase 3 data in Atopic Dermatitis next important catalyst. As we noted before, we see $25/sh upside on positive data and $50-$60/sh downside on negative data. Investors are concerned that overhang due to the patent case could limit the upside with Dupilumab phase 3 data. Regeneron has said Dupilumab data would come in 1H16 while Sanofi (SNY) has said SOLO-1/2 data will readout in Q116 while CRONOS will readout in Q216.

    Shares of Regeneron Pharmaceuticals have gained 1.3% to $368.55 at 2:40 p.m. today, while Amgen has advanced 0.6% to $149.36, and Sanofi has climbed 2.8% to $39.84.